Device Trial Radar · NCT06247397
Effect of HIgh-flow Therapy in Long-term Oxygen Therapy
Last checked: Nov 19, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
310
Planned (sponsor's estimate)
Start
Jun 10, 2024
Primary completion
Dec 2028
Study completion Dec 2029
Sponsor
- Lead sponsor
- Skane University HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Uppsala University Hospital; Region Stockholm; Region Örebro County; Blekinge County Council Hospital; Blekinge Institute of Technology; Lund University; Region Östergötland; Vastra Gotaland Region; Region Västerbotten; Landstinget i Värmland; ResMed; Swedish Heart Lung Foundation; The Swedish Research Council
- First posted
- Feb 7, 2024
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a registry-based, randomized, controlled clinical trial of the effect of added high-flow oxygen therapy (using the device Lumis HFT) during one year in people with long-term oxygen therapy (LTOT) for chronic obstructive pulmonary disease (COPD) or interstitial lung disease (ILD).
Conditions
- Chronic Obstructive Pulmonary Disease Severe
- Interstitial Lung Disease
- Chronic Respiratory Failure With Hypoxia
Interventions
Added high-flow oxygen therapyDevice
Added high-flow oxygen therapy using the device Lumis HFT during nighttime and at the patient's discretion daytime, with the usual care (low-flow oxygen therapy) the rest of the time.
Standard careOther
Standard care with low-flow oxygen therapy in accordance with clinical routine.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to first hospitalization or death from all causesTime frame: 1 year
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Department of Heart, Lung and Clinical Physiology, Örebro University Hospital
Örebro, Sweden · Recruiting
Research Unit, Blekinge University of Technology
Karlskrona, Blekinge County, Sweden · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.